We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Share this :
Print
GenScript ACE-2 Fc Chimera, Human (CHO-expressed)100ug
GenScript ACE-2 Fc Chimera, Human (CHO-expressed)100ug - GSCRPT (Additional S&H or Hazmat Fees May Apply)
List Price
$380.00
Your Price
$380.00
HOW MUCH YOU SAVE:
0.00 %
NETA PART: | GSCRPT-Z03516-100 |
MFG.PART: | Z03516-100 |
UNSPSC: | 12352202 |
Manufacturer: | GenScript USA Inc |
Product Introduction
Species | Human | ||||
Protein Construction |
| ||||
Purity | > 95% as analyzed by SDS-PAGE | ||||
Endotoxin Level | < 1 EU/μg of protein by gel clotting method | ||||
Biological Activity | ACE-2, hFc, Human (CHO-expressed) can bind with S-RBD in functional ELISA assay. | ||||
Expression System | CHO | ||||
Theoretical Molecular Weight | 110.5 kDa | ||||
Formulation | Supplied as a solution in PBS pH 7.4. | ||||
Concentration | Please refer to the COA for the specific lot. | ||||
Storage & Stability | Upon receiving, this product remains stable for up to 6 months at -20°C or below. Avoid repeated freeze-thaw cycles. |
Background
Target Background | Angiotensin-Converting Enzyme 2 (ACE-2) is an integral membrane protein and a zinc metalloprotease of the ACE family. The ACE family includes somatic and germinal ACE. ACE-2 cleaves angiotensins I and II as a carboxypeptidase. ACE-2 converts angiotensin I to angiotensin 1-9, and angiotensin II to angiotensin 1-7. ACE 2 is also able to hydrolyze apelin-13 and dynorphin-13 with high efficiency. It has high binding affinity to S-RBD. |
Synonyms | Human Angiotensin-Converting Enzyme 2; ACE-2 |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
SKU | GSCRPT-Z03516-100 |
---|---|
Supplier Part Number | Z03516-100 |
UM | EA |
UNSPSC | 12352202 |
Manufacturer | GenScript USA Inc |
ProductLine | GSCRPT |
Qty | 1 |
MinOrderQty | 1 |
Weight | 7.00 |
Lead Time | 7 Business Days |
Hazardous | N |